No profile data available.
Intensity Therapeutics, Inc. (INTS) is a healthcare company in the additional cancer treatment drugs industry, based in Shelton, United States, with about 5 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$11.61 million. Its market capitalization was $11.85 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States.
Intensity Therapeutics reported $0 in revenue for fiscal year 2025.
$11.85 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include AlphaTON Capital Corp. (ATON), Tempest Therapeutics, Inc. (TPST), Lantern Pharma Inc. (LTRN), Lisata Therapeutics, Inc. (LSTA).